98%(HPLC), Analytical standard; Cas No.:64858-90-8
An active ingredient in preparations for the treatment of Parkinson’s disease.
98%(HPLC), Analytical standard; Cas No.:1029364-73-5
Irinotecan Related Compound E
Budesonide EP impurity A;CAS NO.:13951-70-7;
Desoximetasone Impurity D;CAS NO.:24916-90-3;
ethyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxoquinoline-3-carboxylate (CAS NO.:112811-71-9)
1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid (CAS NO.: 112811-72-0)